Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

early diagnosis

This page shows the latest early diagnosis news and features for those working in and with pharma, biotech and healthcare.

New diagnosis pathway has been launched to mark European Myeloma Day

New diagnosis pathway has been launched to mark European Myeloma Day

The Myeloma Diagnosis Pathway aims to improve early diagnosis for patients. ... MPE’s research report, 'Myeloma Diagnosis Across Europe – The Diagnosis Experiences of European Myeloma Patients and Perspectives from European Haematologists’, has

Latest news

More from news
Approximately 3 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • Genomic medicine: collaborating for diverse data Genomic medicine: collaborating for diverse data

    Neurology:the complex nature of neurological diseases means there are major challenges in diagnosis, management and treatment. ... This can lead to novel therapeutic strategies. Biomarker discovery:genome data can help in identifying biomarkers, which

  • The importance of AI in improving patient care The importance of AI in improving patient care

    We can also expect to see new AI applications giving HCPs alternative training options with naturalistic simulations, insights into diagnosis through cognitive technologies, early disease detection via screening reviews, patient movement

  • Rare diseases: not so rare after all Rare diseases: not so rare after all

    The prevalence impacts all aspects of medical management, from the likelihood of an early and correct diagnosis to the availability of specialised doctors and the chances that treatment options are available, ... Innovation continues to contribute to

  • Preparing for a new era in Alzheimer’s disease Preparing for a new era in Alzheimer’s disease

    The early signs of AD are often overlooked or put down to normal ageing, delaying diagnosis further. ... Education on the symptoms and progressive nature of AD is needed, along with a better understanding of the importance of seeking a diagnosis as early

  • Unlocking the potential of data sharing Unlocking the potential of data sharing

    From early-stage clinical research to screening, diagnosis and patient monitoring and innovative collation and interpretation of data, the sharing of such data is key.

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

  • Owlstone Medical bolsters management team Owlstone Medical bolsters management team

    Billy Boyle, co-founder and chief executive officer of Owlstone Medical, said: “Owlstone Medical was created very specifically to advance our breathalyzer for very early stage diagnosis of disease when it

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • How whole genome sequencing is revolutionising the rare disease patient experience How whole genome sequencing is revolutionising the rare disease patient experience

    In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions for ... Ultimately, WGS has demonstrated the ability to benefit

  • Rare Disease Day – looking to the future with hope Rare Disease Day – looking to the future with hope

    Early diagnosis and new technologies. Shortening the diagnostic journey is a major focus of advocacy groups; a correct diagnosis can take 6–8 years for some rare diseases and involves visits ... Two recent publications also illustrate the exciting

  • Cancer: Beyond the Backlog Cancer: Beyond the Backlog

    Central to these ambitions was a focus on early diagnosis of disease, together with ensuring access to innovative treatments for patients. ... There is alignment here with the focus in the Long Term Plan, as well as the Early Detection and Diagnosis

  • What does the future hold for Light-chain Amyloidosis?

    As with any disease, the prognosis for patients with AL amyloidosis is improved by early diagnosis and treatment. ... Secondly, diagnosis barriers can make it more difficult to accurately size the market.

  • What do NHS changes and the Life Sciences Vision mean for medicines? What do NHS changes and the Life Sciences Vision mean for medicines?

    These seven challenges (or ‘’silent pandemics’ as the LSV calls them) are neurodegeneration; early diagnosis and treatment in cancer, including immune therapies; vaccine development and manufacturing; cardiovascular disease and obesity;

More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....

Quick links